Salix Pharma company information, Employees & Contact Information

Physician Views: Viberzi versus Xifaxan – who is winning the IBS-D land-grab? FirstWord Pharma

Salix survey shows many IBS patients suffer in silence for years before speaking to their physician Fierce Pharma

Eight opponents achieve revocation of Salix’s rifaximin patent at EPO JUVE Patent

Becoming omni-ready: A pharma playbook from Salix and Syneos Health Communications Medical Marketing and Media

SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022 PR Newswire

UPDATE: Valeant successfully fends off Endo, seals deal with Salix BioPharma Dive

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence Yahoo Finance

Bausch loses Salix president—and turnaround architect—to precision GI company Fierce Pharma

Salix's first streaming TV ad for Relistor introduces MU-MAN Fierce Pharma

Debt-laden Valeant goes deeper in the hole with $200M-plus Salix settlement Fierce Pharma

Salix arms its GI salesforce with 2nd liver treatment in Doptelet co-promotional deal Fierce Pharma

Salix teams with Bellamy Young to remove the stigma around HE Fierce Pharma

Valeant touts Salix sales-force scale-up amid rumors of mass rep exit Fierce Pharma

Salix gets real patient to talk about the risk of overt hepatic encephalopathy Fierce Pharma

Salix adds melody to Xifaxan campaign, running TV spot with 'Scandal' actor Bellamy Young Fierce Pharma

Salix taps TikTok for the first time in constipation campaign push Fierce Pharma

Hey, doctor, Salix says. Check in with your IBS patients—they're suffering in the pandemic Fierce Pharma

Alvogen's bid to force FDA to approve generic to Bausch's Xifaxan shot down by federal court Fierce Pharma

Salix's giant inflatable 'Captain Colon' embarks on colon health awareness tour Fierce Pharma

Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra Fierce Pharma

Debt-ridden Valeant invests $27.5M in manufacturing Fierce Pharma

Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease PR Newswire

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 PR Newswire

SEC investigating former Salix Pharma execs, Reuters reports The Business Journals

Salix Pharmaceuticals’ inventory woes ruined potential Allergan buyout BioPharma Dive

Salix's Relistor has its chance to get a jump on AZ's new constipation med Fierce Pharma

Bausch Health to purchase majority of Synergy Pharmaceuticals' assets, including Trulance FirstWord Pharma

FDA Rejects Salix Pharma's IBS Drug Xifaxan RTTNews

With a few short words, Salix Pharmaceuticals as a company disappears WRAL Techwire

‘Organic’ growth and ‘pivoting’ at Bausch Health? One analyst begs to disagree Fierce Pharma

Bausch may have shed the Valeant name, but it still leans on price hikes: analyst Fierce Pharma

Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic Fierce Pharma

Valeant Sweetens Salix Deal to $173 Per Share After Teaming Up With Ackman and Endo International Withdraws BioSpace

Takeda to buy Ariad under $5.2-billion deal, boosting oncology portfolio FirstWord Pharma

Bausch Health says US court ruling blocks Norwich's Xifaxan generic until 2029 FirstWord Pharma

Bausch Health inks $200M ‘stalking horse’ deal for bankrupt Trulance maker Synergy Fierce Pharma

HHS issues rare 'fraud alert' encouraging pharma to nix paid doctor speaker programs Fierce Pharma

Constipation prescription awareness remains low despite known risks of long-term OTC meds: report Fierce Pharma

Moods change with the months? Bausch has a seasonal depression drug TV campaign for you Fierce Pharma

Which M&A made our best-and-worst ballot? Vote for the deals of the decade Fierce Pharma

With FDA nod for a Novartis castoff, Pharming is set to market a second rare disease drug Fierce Pharma

Intra-Cellular crowned your winner of the Fierce Madness Drug Ad Tournament 2023 Fierce Pharma

Can tiny Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so Fierce Pharma

Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says Fierce Pharma

Pain drug stigma stops patients from getting meds but opioid side effects, fatalities muddy waters Fierce Pharma

Liver disease misinformation rampant on TikTok: study Fierce Pharma

Takeda’s $5.2B deal for Ariad and $125M with Maverick, Valeant’s $820M Dendreon sell to Chinese company, and more Fierce Pharma

Blackrock Neurotech uses next-gen 'thought-to-cursor' tech to allow paralyzed patients to create art Fierce Pharma

Lupin launches Salix Pharma’s Zaxine in Canada Mint